Boltz Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 47

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $110M

  • Investors
  • 12

Boltz General Information

Description

Developer of biomolecular foundation models designed to facilitate computational drug discovery. The company's platform utilizes high-performance compute, generative artificial intelligence, and agentic workflows to provide protein structure prediction, binding affinity estimation, and small-molecule design, enabling pharmaceutical and biotechnology scientists to design thousands of molecules and accelerate hit discovery through in silico modeling.

Contact Information

Website
www.boltz.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 857 Beacon Street
  • Apartment 63
  • Boston, MA 02215
  • United States
+1 (857)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 857 Beacon Street
  • Apartment 63
  • Boston, MA 02215
  • United States
+1 (857)

Boltz Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boltz Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 19-Nov-2026 $110M Completed Generating Revenue
1. Seed Round 09-Jan-2026 Completed Generating Revenue
To view Boltz’s complete valuation and funding history, request access »

Boltz Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Boltz’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Boltz Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boltz Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Benchling VC-Backed Company Minority
Bessemer Venture Partners Venture Capital Minority
F-Prime Venture Capital Minority
Greycroft Venture Capital Minority
Hummingbird VC-Backed Company Minority
You’re viewing 5 of 12 investors. Get the full list »

Boltz FAQs

  • When was Boltz founded?

    Boltz was founded in 2024.

  • Where is Boltz headquartered?

    Boltz is headquartered in Boston, MA.

  • What is the size of Boltz?

    Boltz has 47 total employees.

  • What industry is Boltz in?

    Boltz’s primary industry is Discovery Tools (Healthcare).

  • Is Boltz a private or public company?

    Boltz is a Private company.

  • What is Boltz’s current revenue?

    The current revenue for Boltz is .

  • How much funding has Boltz raised over time?

    Boltz has raised $138M.

  • Who are Boltz’s investors?

    Benchling, Bessemer Venture Partners, F-Prime, Greycroft, and Hummingbird are 5 of 12 investors who have invested in Boltz.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process